MRVI vs. ARES
Compare and contrast key facts about Maravai LifeSciences Holdings, Inc. (MRVI) and Ares Management Corporation (ARES).
Performance
MRVI vs. ARES - Performance Comparison
Loading graphics...
MRVI vs. ARES - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
MRVI Maravai LifeSciences Holdings, Inc. | -12.92% | -40.37% | -16.79% | -54.23% | -65.85% | 49.38% | -6.03% |
ARES Ares Management Corporation | -33.65% | -5.72% | 52.68% | 79.52% | -12.75% | 77.75% | 5.51% |
Fundamentals
MRVI:
$410.56M
ARES:
$23.40B
MRVI:
-$0.90
ARES:
$2.40
MRVI:
2.20
ARES:
3.60
MRVI:
$185.74M
ARES:
$6.47B
MRVI:
$33.99M
ARES:
$2.74B
MRVI:
-$164.19M
ARES:
$2.24B
Returns By Period
In the year-to-date period, MRVI achieves a -12.92% return, which is significantly higher than ARES's -33.65% return.
MRVI
- 1D
- -1.74%
- 1M
- -21.61%
- YTD
- -12.92%
- 6M
- -9.87%
- 1Y
- 31.02%
- 3Y*
- -41.33%
- 5Y*
- -39.24%
- 10Y*
- —
ARES
- 1D
- -3.02%
- 1M
- -5.40%
- YTD
- -33.65%
- 6M
- -29.63%
- 1Y
- -26.47%
- 3Y*
- 11.65%
- 5Y*
- 16.55%
- 10Y*
- 26.47%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
MRVI vs. ARES — Risk / Return Rank
MRVI
ARES
MRVI vs. ARES - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Maravai LifeSciences Holdings, Inc. (MRVI) and Ares Management Corporation (ARES). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| MRVI | ARES | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.39 | -0.57 | +0.97 |
Sortino ratioReturn per unit of downside risk | 1.15 | -0.57 | +1.72 |
Omega ratioGain probability vs. loss probability | 1.13 | 0.92 | +0.21 |
Calmar ratioReturn relative to maximum drawdown | 0.67 | -0.51 | +1.18 |
Martin ratioReturn relative to average drawdown | 1.55 | -1.29 | +2.84 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| MRVI | ARES | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.39 | -0.57 | +0.97 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.53 | 0.45 | -0.99 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.73 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.49 | 0.59 | -1.08 |
Correlation
The correlation between MRVI and ARES is 0.25, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
MRVI vs. ARES - Dividend Comparison
MRVI has not paid dividends to shareholders, while ARES's dividend yield for the trailing twelve months is around 5.25%.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
MRVI Maravai LifeSciences Holdings, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
ARES Ares Management Corporation | 5.25% | 3.29% | 2.10% | 2.59% | 3.57% | 2.31% | 3.40% | 3.59% | 7.50% | 5.65% | 4.32% | 6.81% |
Drawdowns
MRVI vs. ARES - Drawdown Comparison
The maximum MRVI drawdown since its inception was -97.16%, which is greater than ARES's maximum drawdown of -49.73%. Use the drawdown chart below to compare losses from any high point for MRVI and ARES.
Loading graphics...
Drawdown Indicators
| MRVI | ARES | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -97.16% | -49.73% | -47.43% |
Max Drawdown (1Y)Largest decline over 1 year | -29.93% | -49.05% | +19.12% |
Max Drawdown (5Y)Largest decline over 5 years | -97.16% | -49.73% | -47.43% |
Max Drawdown (10Y)Largest decline over 10 years | — | -49.73% | — |
Current DrawdownCurrent decline from peak | -95.33% | -44.13% | -51.20% |
Average DrawdownAverage peak-to-trough decline | -66.75% | -10.91% | -55.84% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 12.84% | 19.49% | -6.65% |
Volatility
MRVI vs. ARES - Volatility Comparison
Maravai LifeSciences Holdings, Inc. (MRVI) and Ares Management Corporation (ARES) have volatilities of 15.37% and 15.15%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| MRVI | ARES | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 15.37% | 15.15% | +0.22% |
Volatility (6M)Calculated over the trailing 6-month period | 43.81% | 33.37% | +10.44% |
Volatility (1Y)Calculated over the trailing 1-year period | 72.32% | 46.29% | +26.03% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 73.79% | 36.85% | +36.94% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 73.39% | 36.37% | +37.02% |
Financials
MRVI vs. ARES - Financials Comparison
This section allows you to compare key financial metrics between Maravai LifeSciences Holdings, Inc. and Ares Management Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities